Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep-Oct;91(S2):S124-S126.
doi: 10.25259/IJDVL_575_2024.

Topical atorvastatin in the management of porokeratosis

Janaani P  1 , Debajyoti Chatterjee  2 , Rahul Mahajan  1
Affiliations
Free article

Topical atorvastatin in the management of porokeratosis

Janaani P et al. Indian J Dermatol Venereol Leprol. 2025 Sep-Oct.
Free article
No abstract available

PubMed Disclaimer

References

    1. Vargas-MoraP,Morgado-CarrascoD,Fustà-NovellX,.Porokeratosis: A review of its pathophysiology, clinical manifestations, diagnosis, and treatment.Actas Dermosifiliogr (Engl Ed).2020; 111:545-60
    1. AtzmonyL,LimYH,HamiltonC,LeventhalJS,WagnerA,PallerAS,et al.Topical cholesterol/lovastatin for the treatment of porokeratosis: A pathogenesis-directed therapy.J Am Acad Dermatol.2020; 82:123-31
    1. BythLA,BythJ,.Topical simvastatin-cholesterol for disseminated superficial actinic porokeratosis: An open-label, split-body clinical trial.Australas J Dermatol.2021; 62:310-13
    1. AtzmonyL,ChoateKA,.Second-hit somatic mutations in mevalonate pathway genes underlie porokeratosis.J Invest Dermatol.2019; 139:2409-11
    1. CalayD,Vind-KezunovicD,FrankartA,LambertS,PoumayY,GniadeckiR,.Inhibition of Akt signaling by exclusion from lipid rafts in normal and transformed epidermal keratinocytes.J Invest Dermatol.2010; 130:1136-45

LinkOut - more resources